Vascular cognitive impairment has been traditionally defined by structural pathology, an accumulation of infarcts, leading to progressive cognitive decline. Recent evidence, however, suggests that cognitive impairment may be independently mediated by hemodynamic dysfunction, including global and hemispheral hypoperfusion and altered cerebral blood flow regulation. In this review, we examine evidence for the contribution of hemodynamic impairment to cognitive dysfunction in the setting of large vessel disease, cardiac failure, and microvascular disease. If there is a hemodynamic component of vascular cognitive impairment, then treatments proposed to correct impaired vascular physiology may reasonably be expected to treat the cognitive dysfunction as well. (Stroke. 2011;42:221-226.) Key Words: brain recovery Ⅲ cerebral hemodynamics Ⅲ cognitive impairment Ⅲ EC/IC bypass Ⅲ reperfusion Ⅲ
T he ancient Romans had an exquisitely engineered aqueduct system to supply water to their cities. Originating in surrounding hills, the system required a descent in elevation of exactly 34 cm/km to keep the water flowing smoothly. Too steep a gradient and the water would overflow; too flat and the system would clog. For hundreds of years, the system brought Ͼ50 million gallons of water per day to the citizens of Rome for drinking, bathing, and irrigation. Like with the historical water needs of the citizens of Rome, brain tissue requires a well-regulated system to maintain functional homeostasis. Obstructed conduits, inadequate pumping force, and dysfunctional vessels can reduce flow or alter homeostatic blood flow regulation. Cognitive function, perhaps more than any other brain process, appears to be sensitive to changes in hemodynamic state. 1
Structural Versus Hemodynamic Impairment
Vascular cognitive impairment (VCI) has been difficult to characterize because of its multifactorial etiology and poor standardization of measurement. Structural pathology of both Alzheimer disease (AD) and vascular dementia is reported to be present in a high percentage of cases diagnosed clinically as either 1 condition or the other; infarcts and white matter lesions are found in brains of 60% to 90% of patients with AD, and plaques and tangles are found in more than one third of those diagnosed with vascular dementia. 2 Among vascular cases, both the accumulation of small infarcts 3 and the strategic placement of large infarcts 4 are well described to produce cognitive impairment. Although structural pathology is unquestionably important in the development of dementia, there is burgeoning evidence that cerebral hemodynamic impairment may be a direct mediator of cognitive dysfunction and decline.
Hemodynamic abnormalities, specifically cerebral hypoperfusion and impaired cerebral vasomotor reactivity (CVR), are present in a variety of cerebrovascular conditions. Our central thesis for the purposes of this review is that whereas structural pathology may reflect irreversible, end-organ damage leading to permanent cognitive dysfunction, hemodynamic causes of cognitive decline may be reversible and thus a target for treatment. The purpose of this review is to consider the evidence for hemodynamic mediation of cognitive dysfunction. We examine vascular-related cognitive impairment at 3 levels of ischemic disease: hemispheral hypoperfusion caused by carotid occlusive disease, global cerebral hypoperfusion produced by cardiac failure, and microvascular pathology leading to loss of vasomotor reactivity and cerebral blood flow (CBF) autoregulation.
Definition of VCI
The set of clinical elements that defines VCI continues to be debated. 5 Although there is an historical emphasis on memory dysfunction in dementia, newer evidence shows that smallvessel disease in the frontal lobes may be associated with disruption of executive function and processing speed in the absence of difficulties in new learning and amnestic func-tion. 6 Memory abnormality is therefore not necessary for a diagnosis of VCI, reflected in the recently established harmonization standards. 7 However, because AD and VCI can co-occur and interact in a manner not identifiable until pathology is verified, establishing "pure cases" of VCI remains problematic. In addition, some cardiovascular conditions are associated with hippocampal atrophy 8, 9 contributing directly to memory loss. We therefore take the position that the rubric of vascular cognitive disorders is an umbrella concept, encompassing any vascular condition that is sufficient to produce cognitive change.
An important step forward has been the recognition that vascular dementia, like AD, represents only 1 end of the severity continuum. At the other end lies mild deficits with minimal impact on daily activities, sometimes referred to as vascular cognitive impairment no dementia or nonamnestic mild cognitive impairment. 10 These are important to identify because longitudinal studies show that individuals with such early changes are at significant risk for developing more disabling syndromes. 11 Mild syndromes were not recognized as VCI initially because of the belief that the end product of the responsible vascular disease is neuronal death, whether from large territory infarction or lacunar disease. Consequently, a major underlying assumption is that function, like brain tissue, is irretrievably lost. There is evidence, as discussed subsequently, to contradict this assumption. Finally, it is interesting to note parallels between the dynamic nature of cognitive functions such as information processing, attention and working memory, and the dynamic physiology of blood flow; these cognitive functions appear uniquely susceptible to hemodynamic compromise, which may help further distinguish cognitive dysfunction originating from vascular causes as opposed to cortical degenerative causes like AD.
Hemispheral Hypoperfusion as a Reversible Pathology for Cognitive Decline
Perhaps the clearest evidence for a cerebral hemodynamic effect is in large-vessel disease producing hemispheral hypoperfusion. Here, a drop in perfusion pressure to a cerebral hemisphere supplied by a blocked carotid artery induces a series of well-described hemodynamic responses, including dilation of cerebral arterioles and increase of oxygen extraction fraction to preserve aerobic metabolism. 12 Further reduction in perfusion pressure results in ischemia and then frank infarction. These hemodynamic responses, part of the autoregulatory process, allow reversibility of ischemia and, at least under some circumstances, recovery of brain function. 13 The association between carotid occlusive disease and dementia was first reported by Miller Fisher in 1954 in a patient with bilateral carotid occlusion and progressive dementia. 14 Many carotid treatment studies have compared preand postoperative cognitive performance with inconsistent treatment effects on cognition. [15] [16] [17] Systematic reviews of the impact of carotid disease on cognitive dysfunction have been inconclusive. 18 -20 A recent review of 32 papers in which cognition was assessed before and after carotid endarterectomy or carotid artery stenting found that 5 reported cognitive decline, 6 documented no significant change, and in the remaining, percentages of improvement varied across cognitive domains. 21 Unfortunately, measurement of cognitive impairment varied widely, and none of the studies measured blood flow.
The argument that hypoperfusion is an independent cause for cognitive impairment in carotid occlusive disease is strengthened by studies reporting cognitive impairment in patients with carotid stenosis in the absence of frank infarction. Bakker et al 22 reported cognitive impairment in 39 cases with cerebral or retinal transient ischemic attacks but no stroke on MRI. Johnston et al examined the relationship between side of carotid stenosis and cognitive impairment among patients with high-grade carotid disease but no infarction. 23 Cognitive dysfunction and cognitive decline, measured by Mini-Mental State Examination, were correlated with left but not right internal carotid artery stenosis. The authors concluded that because the Mini-Mental State Examination is more sensitive to left hemispheral dysfunction, the stenosis was more than a marker of generalized cognitive dysfunction but a causal factor in the dysfunction. Although the association was statistically significant, cognitive impairment occurred in only 34% of patients with severe stenosis, whereas the remaining patients with stenosis had normal cognition. 24 Again, however, hemodynamic measurements were not made.
Blood flow was measured by Tatemichi et al in a 55-yearold man with bilateral internal carotid artery occlusions presenting with a subacute onset of severe behavioral and cognitive changes. 25 Quantitative CBF and positron emission tomography studies showed a 40% to 50% reduction in blood flow and metabolism. After extracranial-intracranial bypass, the patient demonstrated neuropsychological improvement accompanied by significant increases in CBF and metabolism. In a larger case series, 25 patients with unilateral carotid occlusion and poor neuropsychological performance underwent extracranial-intracranial bypass. 26 Cognitive improvement was associated with increased CBF, increased CVR, and decreased oxygen extraction fraction. The possibility that extracranial-intracranial bypass can improve cognition or prevent its decline is being formally tested in the National Institute of Neurological Disorders and Stroke-sponsored Randomized Evaluation of Carotid Occlusion and Neurocognition (RECON) trial, 27,27a an ancillary study of the Carotid Occlusion Surgery Study (COSS). In this study, positron emission tomography measurements are taken in all patients with recently symptomatic carotid occlusion. Among those with increased oxygen extraction fraction, indicating socalled Stage II hemodynamic failure, half receive extracranial-intracranial bypass and half best medical therapy alone. Hemisphere-specific and global cognitive tests are administered at baseline and 2 years after randomization. The differences in 2-year cognitive scores between the surgical and medical groups will determine whether direct cerebral hemodynamic treatment of patients with known hemodynamic failure can benefit from hemispheral reperfusion. Demonstration of a positive effect of revascularization on cognition would constitute the first proof of reversible cognitive impairment due to a hemodynamic cause within the context of a randomized clinical trial.
Cognitive Impairment in Cardiac Disease Due to Global Cerebral Hemodynamic Dysfunction
Congestive heart failure (CHF) is a model for the effects of whole-brain hypoperfusion on cognitive dysfunction. Although cardiac embolism and decreased CBF may both contribute to cognitive impairment, 28 as heart failure progresses to more severe stages, reduced CBF correlates with a rising prevalence of cognitive dysfunction. 29 Choi et al found that global CBF was 19% less in patients with severe CHF than in control subjects. 30 Unlike embolic stroke, which produces focal deficits, low CBF affects more complex cognitive tasks such as memory, attention, and executive skills subserved by distributed brain regions.
Zuccala et al were among the first to show that cognition was affected by cardiac failure. 31 Among 57 elderly individuals with chronic CHF, poorer cognition was associated with left ventricular ejection fraction Յ30%. With finer-grained neuropsychological assessment, it has become increasingly apparent that not all cognitive functions are equally susceptible to global hemodynamic compromise. Vogels et al studied individuals with New York Heart Association Stage II and III CHF. 32 Patients with CHF had greater deficits in widely distributed processing skills, whereas focal cognitive functions such as language were not different between patients and control subjects. We studied 116 consecutive candidates for transplant and compared their function with age-matched norms. 33 We also found that more broadly dispersed spheres of cognitive functions were affected in patients with severe heart failure.
The opportunity to confirm further the relationship between cerebral hemodynamics and cognition has come from the restoration of cardiac output through medical or surgical intervention. Zuccala et al studied retrospectively 1220 older patients with heart failure and found that those starting angiotensin-converting enzyme inhibitors, a drug class known to have positive effects on CBF, had an increased probability of improving cognitive function during hospital stay. 34 Other evidence has been derived by comparisons before and after cardiac transplantation. Several recent studies showed cognitive benefit after transplantation. 35, 36 Mechanistic support for improvement in CBF that would account for concomitant changes in cognition has been provided by blood flow and transcranial Doppler studies. 37, 38 Whereas cerebral hypoperfusion seems to mediate cognitive impairment and recovery, there appears also to be a risk to restoring whole-brain blood flow too quickly, similar to reperfusion injury after carotid endarterectomy or angioplasty. 39 We studied 69 consecutive patients who had just undergone implantation with a left ventricular assist device and found that 19 developed neurological dysfunction, mainly cognitive slowing and inattention. The risk of this condition correlated with an increased cardiac index, the effect attributed to mild cerebral edema. Reduction of left ventricular assist device outflow in 16 of the 19 symptomatic patients led to improvement in symptoms in 14 of them.
Collectively, the evidence from these heart failure studies suggests that optimization of cognitive function occurs in the middle range of CBF (Figure 1) . At the higher and lower ends of the spectrum, there is degradation of function; normalizing CBF reverses the cognitive dysfunction.
Cognitive Impairment Related to Vascular Dysfunction in Microvascular Ischemia
In the absence of chronic hemispheric hypoperfusion caused by large-vessel stenosis or global cerebral hypoperfusion produced by cardiac failure, the cerebral microvasculature may undergo altered hemodynamic function in patients with stroke risk factors. Hypertension, diabetes, and direct effects on the endothelium have been shown to be associated with changes in CBF and vasoreactivity in this population. 40, 41 Demonstrating a causal link between these hemodynamic changes and cognitive impairment has been more difficult to prove, however, in part because of the co-occurrence of small-vessel infarction. Nonetheless, the association is worth considering because, like global and hemispheral hemodynamic impairment, the potential exists for ameliorating cognitive impairment by reversing abnormal microvascular hemodynamics.
Hypertension has been the most studied risk factor for cognitive impairment because of its effects on vascular function. In 1 study, carotid femoral pulse wave velocity, a measure of arterial stiffness, correlated with poorer scores on the Mini-Mental State Examination among elderly patients with never-treated essential hypertension. 42 Silent infarction was not evaluated in this study, however, so it may have been that those with greater arterial stiffness had silent infarcts to explain the cognitive impairment. A similar study in elderly and middle-aged men showed pulse wave velocity associated with lower processing capacity and executive functioning and increased intima-media thickness, a preatherosclerotic marker correlating with memory impairment. 43 With no imaging in this study, however, frank infarction as an intermediary between vascular dysfunction and cognitive impairment could not be ruled out. In the Johnston study described in the carotid section, it was also shown that intima-media thickness was associated with cognitive impairment, suggesting that 
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intima-media thickness may be a nonlateralizing marker of vascular dysfunction that was contributing to cognitive impairment.
In addition to hypertension, hypotension may also play a hemodynamic role in the development of cognitive impairment. 44, 45 This hypothesis has appeal because CBF is known to be low in patients with dementia, 46 and cerebral hypoperfusion appears to be associated with cognitive impairment in large-vessel disease and cardiac failure as also discussed previously. Low CBF imaged in dementia may be a reflection of lower metabolism or a consequence of the dementing process, however. 47 An additional pathophysiological link between hemodynamics and cognitive impairment concerns white matter hyperintensities (WMHs). There is evidence that WMHs arise from chronic hypoperfusion. 48 CVR has also been shown to be lower when WMHs are present. 49 Regardless of cause, these pathological changes have been associated with cognitive decline. 50, 51 An association between WMH and impaired hemodynamic function was demonstrated by Fu et al who investigated patients Ͼ60 years of age with WMH on MRI but no stroke or significant large-vessel stenosis. 52 They showed that extent of these lesions correlated inversely with CVR measured by transcranial Doppler.
Other stroke risk factors have also been linked to impaired cerebral hemodynamics. Giannopoulos et al recently showed an association between metabolic syndrome and impaired CVR in 83 patients in the hemisphere opposite to that supplied by a stenotic carotid artery, suggesting that metabolic syndrome, with its associated endothelial effects, 53 alters cerebral hemodynamics more broadly than through unilateral hemispheral hypoperfusion. Furthermore, in cerebral autosomal dominant arteriopathy with subcortical infarction and leukoencephalopathy (CADASIL), a condition associated with WMH and early dementia, flow-related vascular dysfunction appears to occur even before vascular smooth muscle degeneration and granular osmophilic material deposition has taken place. 54 Given the evidence that cerebral hemodynamic dysfunction appears to have an independent association with cogni-tive impairment, the question arises whether treatment of the hemodynamic impairment can reverse cognitive impairment. Blood pressure management may be 1 effective way to reverse the effects of hemodynamic impairment. In hypertensives who develop dementia, the prevention of hypotension has been shown to protect against cognitive decline. 55 In this study of patients with vascular dementia, those who had hypertension kept below systolic pressure of 135 mm Hg had deterioration of cognitive function, whereas those kept 135 to 150 mm Hg improved. In addition, some have evaluated antihypertensives with known positive effects on CBF. The Cardiovascular Health Cognition substudy showed that patients taking centrally acting angiotensin-converting enzyme inhibitors had a 65% per year reduction in decline of Mini-Mental State Examination scores compared with others taking nonblood flow-related antihypertensives. An ongoing National Institutes of Health-sponsored, randomized clinical trial is assessing cognitive function, CBF, and CVR among 100 elderly, hypertensive patients taking 1 of 3 antihypertensives with varying effects on CBF. 56 
Conclusions
The relationship between vascular pathophysiology and cognitive impairment is complex, as shown in Figure 2 . Stroke risk factors contribute to vascular changes, which in turn cause both structural pathology and chronic hemodynamic failure. These end-organ effects in the brain produce cognitive impairment either directly or through the further influence of autoregulatory loss and accumulation of WMH. Genetic factors and AD pathology may further mediate the effects of vascular dysfunction on cognitive impairment. Although the prevention of structural pathology will remain an important tenet in the treatment of VCI, the evidence for the relationship between reversibility of hemodynamic dysfunction and the reversibility of cognitive impairment appears strong enough to warrant serious clinical attention and continued scientific study.
Future Directions
Based on the successes and failures of clinical studies discussed in this review, we propose that certain key variables should be present in any future study of the relationship between blood flow and cognition (Table) . First, the study must include a quantifiable measure of cerebral hemodynamics such as blood flow by positron emission tomography or arterial spin labeling MRI, autoregulation by transcranial Doppler vasoreactivity, 57 or hypercapnia-induced blood oxygen level-dependent changes by functional MRI. 58 Second, the cognitive assessment must include functions that are sensitive to hypoperfusion (eg, attention and executive function) and specific to the disease state being studied (eg, hemisphere-specific for carotid disease, bihemispherical functions for cardiac failure). Third, presence prior strokes, small vessel infarcts, microbleeds, 59 and WMHs must be examined as covariates. Fourth, depression, renal failure, hepatic dysfunction, pulmonary disease, and other variables that can independently alter cognition must be controlled for or serve as exclusions. Only with careful study design and thoughtful consideration of potentially relevant variables will the complex relationship between blood flow and cognition be disentangled enough to alter our patients' clinical course and move the field forward. PET indicates positron emission tomography; ASL, arterial spin labeling; TCD, transcranial Doppler; fMRI, functional MRI; BOLD, blood oxygen leveldependent; FLAIR, fluid-attenuated inversion recovery.
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